VRDN7:01 AMViridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Resultsviridiantherapeutics.com
VRDN6:00 PMViridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Diseaseviridiantherapeutics.com